With a $11 billion price tag, the White House pitches a plan to end hepatitis C
WASHINGTON – The Biden administration is calling on Congress to fund a more than $11 billion program to eliminate hepatitis C in the United States.
It’s a significant price tag for a single line in the broader budget request; while the $11 billion ask would cover five years of the new initiative, it still dwarfs the annual budget request for the entire Food and Drug Administration, at $7.2 billion. The annual request for the Substance Abuse and Mental Health Services Administration also comes in below the hepatitis C topline, at $10.8 billion.
